Weekly Dispatches
Undervalued Shares
Every week, I send out an email with observations about markets, investments, and random other subjects. These emails will help you shape your world-view, they will teach you new investment strategies, and they will also give you new ideas that you can research further.
MOST POPULAR WEEKLY DISPATCHES
Don't invest in it if they don't call you crazy!
13 investment trends for a new world
Investing in Poland (3-part series)
2020 – the year for investing in Europe?
Sark: investment opportunity of a decade
Riches among ruins (3-part series)
A few thoughts on Wirecard
Agfa-Gevaert and activist investing in Europe – a case study
Blogs to Watch (part 1): Lyn Alden
Ferrari – the company, the stock, and my car
Blogs to watch (part 22): Asian Century Stocks
Would you like to learn more about investments in Asia, but haven’t found the right resource yet? Asian Century Stocks will help you broaden your horizon.
How (and why) you should exploit the European equity markets
Europe has dozens of languages and legal systems, and its economies are famously anaemic. It’s still one of the world’s best places to invest in right now, though. How come?
3 British real estate companies that could receive a takeover bid
7 bids already for British real estate companies during the first half of 2021, and investors made an average of 30% overnight. Where are bidders going to strike next?
Concentrated bets – how the world’s best value investors got rich
Many of the world’s richest value investors ignored all advice about not putting all your eggs into one basket. Should you, too, turn diversification on its head?
Blogs to watch (part 21): Paladin Asset Management
Would you like free access to the investment ideas of award-winning fund managers? Paladin Asset Management’s little-known blog is a treasure trove of original thinking.
The “best” coronavirus vaccine and an undervalued stock?
Only 25% of the world have been vaccinated against the coronavirus. Can vaccine company Novavax profit from the other 75%, and make vaccine sceptics fall in love with it?
